175 related articles for article (PubMed ID: 2906465)
21. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
Weiser HF; Gubernatis G; Siewert JR
Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
[TBL] [Abstract][Full Text] [Related]
22. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
Lambert R
J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
[No Abstract] [Full Text] [Related]
23. [H2-blockers in reflux-esophagitis].
Berstad A
Tidsskr Nor Laegeforen; 1983 Jul; 103(19-21):1439-41. PubMed ID: 6138879
[No Abstract] [Full Text] [Related]
24. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
[TBL] [Abstract][Full Text] [Related]
25. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
[TBL] [Abstract][Full Text] [Related]
26. Frequent non-response to histamine H2-receptor antagonists in cirrhotics.
Walker S; Krishna DR; Klotz U; Bode JC
Gut; 1989 Aug; 30(8):1105-9. PubMed ID: 2570008
[TBL] [Abstract][Full Text] [Related]
27. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
28. High doses of ranitidine in patients with reflux oesophagitis.
Jansen JB; Lamers CB
Scand J Gastroenterol Suppl; 1990; 178():42-6. PubMed ID: 2277968
[TBL] [Abstract][Full Text] [Related]
29. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
[TBL] [Abstract][Full Text] [Related]
30. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
Mainguet P
Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
[No Abstract] [Full Text] [Related]
31. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.
Koop H; Hotz J; Pommer G; Klein M; Arnold R
Aliment Pharmacol Ther; 1990 Dec; 4(6):593-9. PubMed ID: 1983342
[TBL] [Abstract][Full Text] [Related]
32. [The effect of H2-receptor blockers (cimetidine and ranitidin) on parotid gland secretion and salivary carbonic anhydrase activity in the rat].
Boros I; Keszler P; Szombath D; Pósch E
Fogorv Sz; 1993 Aug; 86(8):265-73. PubMed ID: 7902302
[TBL] [Abstract][Full Text] [Related]
33. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
Langtry HD; Wilde MI
Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
[TBL] [Abstract][Full Text] [Related]
34. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
35. Reflux esophagitis.
Tytgat GN; Nio CY; Schotborgh RH
Scand J Gastroenterol Suppl; 1990; 175():1-12. PubMed ID: 1978403
[TBL] [Abstract][Full Text] [Related]
36. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
Thomas JM; Misiewicz G
Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
[No Abstract] [Full Text] [Related]
37. Drug therapy of reflux oesophagitis: an update.
Tytgat GN
Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
[TBL] [Abstract][Full Text] [Related]
38. Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine.
Borkent MV; Beker JA
Gut; 1988 Mar; 29(3):385-9. PubMed ID: 3281872
[TBL] [Abstract][Full Text] [Related]
39. The medical therapy of reflux oesophagitis.
Tytgat GN; Nio CY
Baillieres Clin Gastroenterol; 1987 Oct; 1(4):791-807. PubMed ID: 2896523
[TBL] [Abstract][Full Text] [Related]
40. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis.
Hatlebakk JG; Berstad A
Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]